VALBENAZINE TOSYLATE | N218390 | NEUROCRINE BIOSCIENCES INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Neurocrine Biosciences, Inc. v. Zydus Pharmaceuticals (USA) Inc. et al 20 patentsANDA 220272valbenazine | D. Del. | 2025-04-25 | Active | — |
NEUROCRINE BIOSCIENCES, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. et al 20 patentsANDA 220272valbenazine | D.N.J. | 2025-04-25 | Terminated 2025-11-05 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 8039627 | Apr 11, 2031 | — | Yes | Yes | — | — |
| 8357697 | Nov 8, 2027 | — | — | — | — | |
| 10065952 | Oct 28, 2036 | — | Yes | Yes | — | |
| 10844058 | Oct 28, 2036 | — | Yes | Yes | — | |
| 10851103 | Oct 28, 2036 | — | Yes | Yes | — | |
| 10851104 | Oct 28, 2036 | — | Yes | — | — | |
| 10857137 | Oct 10, 2037 | — | — | — | — | |
| 10857148 | Oct 10, 2037 | — | — | — | — | |
| 10874648 | Oct 10, 2037 | — | — | — | — | |
| 10906902 | Dec 22, 2036 | — | Yes | Yes | — | — |
| 10906903 | Dec 22, 2036 | — | Yes | Yes | — | — |
| 10912771 | Oct 10, 2037 | — | — | — | — | |
| 10919892 | Dec 22, 2036 | — | Yes | Yes | — | — |
| 10940141 | Aug 10, 2040 | — | — | — | — | |
| 10952997 | Oct 10, 2037 | — | — | — | — | |
| 10993941 | Oct 10, 2037 | — | — | — | — | |
| 11026931 | Aug 14, 2039 | — | — | — | — | |
| 11026939 | Sep 18, 2038 | — | — | Yes | — | |
| 11040029 | Oct 10, 2037 | — | — | — | — | |
| 11311532 | Sep 18, 2038 | — | — | Yes | — | |
| 11439629 | Oct 10, 2037 | — | — | — | — | |
| 11654142 | Nov 14, 2038 | — | — | — | — |
| Code | Date | Status |
|---|---|---|
| I-925 | Aug 18, 2026 | < 1 year |